Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

Ewing's Sarcoma: An Analysis of miRNA Expression Profiles and Target Genes in Paraffin-Embedded Primary Tumor Tissue.

Parafioriti A, Bason C, Armiraglio E, Calciano L, Daolio PA, Berardocco M, Di Bernardo A, Colosimo A, Luksch R, Berardi AC.

Int J Mol Sci. 2016 Apr 30;17(5). pii: E656. doi: 10.3390/ijms17050656.

2.

c-Myc Represses Tumor-Suppressive microRNAs, let-7a, miR-16 and miR-29b, and Induces Cyclin D2-Mediated Cell Proliferation in Ewing's Sarcoma Cell Line.

Kawano M, Tanaka K, Itonaga I, Iwasaki T, Tsumura H.

PLoS One. 2015 Sep 22;10(9):e0138560. doi: 10.1371/journal.pone.0138560. eCollection 2015.

3.

miR-34a predicts survival of Ewing's sarcoma patients and directly influences cell chemo-sensitivity and malignancy.

Nakatani F, Ferracin M, Manara MC, Ventura S, Del Monaco V, Ferrari S, Alberghini M, Grilli A, Knuutila S, Schaefer KL, Mattia G, Negrini M, Picci P, Serra M, Scotlandi K.

J Pathol. 2012 Apr;226(5):796-805. doi: 10.1002/path.3007.

PMID:
21960059
4.

MicroRNA-301a promotes cell proliferation via PTEN targeting in Ewing's sarcoma cells.

Kawano M, Tanaka K, Itonaga I, Iwasaki T, Tsumura H.

Int J Oncol. 2016 Apr;48(4):1531-40. doi: 10.3892/ijo.2016.3379. Epub 2016 Feb 5.

PMID:
26846737
5.

MiR-125b inhibits cell biological progression of Ewing's sarcoma by suppressing the PI3K/Akt signalling pathway.

Li J, You T, Jing J.

Cell Prolif. 2014 Apr;47(2):152-60. doi: 10.1111/cpr.12093. Epub 2014 Feb 12.

PMID:
24517182
6.

An integrated analysis of miRNA and gene copy numbers in xenografts of Ewing's sarcoma.

Mosakhani N, Guled M, Leen G, Calabuig-Fariñas S, Niini T, Machado I, Savola S, Scotlandi K, López-Guerrero JA, Llombart-Bosch A, Knuutila S.

J Exp Clin Cancer Res. 2012 Mar 20;31:24. doi: 10.1186/1756-9966-31-24.

7.

Differentially expressed miRNAs in Ewing sarcoma compared to mesenchymal stem cells: low miR-31 expression with effects on proliferation and invasion.

Karnuth B, Dedy N, Spieker T, Lawlor ER, Gattenlöhner S, Ranft A, Dirksen U, Jürgens H, Bräuninger A.

PLoS One. 2014 Mar 25;9(3):e93067. doi: 10.1371/journal.pone.0093067. eCollection 2014.

8.

Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.

Manikandan M, Deva Magendhra Rao AK, Arunkumar G, Manickavasagam M, Rajkumar KS, Rajaraman R, Munirajan AK.

Mol Cancer. 2016 Apr 7;15:28. doi: 10.1186/s12943-016-0512-8.

9.

Differential expression of basal microRNAs' patterns in human dental pulp stem cells.

Vasanthan P, Govindasamy V, Gnanasegaran N, Kunasekaran W, Musa S, Abu Kasim NH.

J Cell Mol Med. 2015 Mar;19(3):566-80. doi: 10.1111/jcmm.12381. Epub 2014 Dec 5.

10.

microRNA expression profile in stage III colorectal cancer: circulating miR-18a and miR-29a as promising biomarkers.

Brunet Vega A, Pericay C, Moya I, Ferrer A, Dotor E, Pisa A, Casalots À, Serra-Aracil X, Oliva JC, Ruiz A, Saigí E.

Oncol Rep. 2013 Jul;30(1):320-6. doi: 10.3892/or.2013.2475. Epub 2013 May 15.

PMID:
23673725
11.

Clinico-Pathological Association of Delineated miRNAs in Uveal Melanoma with Monosomy 3/Disomy 3 Chromosomal Aberrations.

Venkatesan N, Kanwar J, Deepa PR, Khetan V, Crowley TM, Raguraman R, Sugneswari G, Rishi P, Natarajan V, Biswas J, Krishnakumar S.

PLoS One. 2016 Jan 26;11(1):e0146128. doi: 10.1371/journal.pone.0146128. eCollection 2016.

12.

The expression profiles of microRNAs in Kaposi's sarcoma.

Wu XJ, Pu XM, Zhao ZF, Zhao YN, Kang XJ, Wu WD, Zou YM, Wu CY, Qu YY, Zhang DZ, Feng YY, Liu JY.

Tumour Biol. 2015 Jan;36(1):437-46. doi: 10.1007/s13277-014-2626-1. Epub 2014 Oct 1.

PMID:
25266797
13.

Tumor suppressive microRNA-138 inhibits metastatic potential via the targeting of focal adhesion kinase in Ewing's sarcoma cells.

Tanaka K, Kawano M, Itonaga I, Iwasaki T, Miyazaki M, Ikeda S, Tsumura H.

Int J Oncol. 2016 Mar;48(3):1135-44. doi: 10.3892/ijo.2016.3317. Epub 2016 Jan 5.

PMID:
26782922
14.

Let-7a is a direct EWS-FLI-1 target implicated in Ewing's sarcoma development.

De Vito C, Riggi N, Suvà ML, Janiszewska M, Horlbeck J, Baumer K, Provero P, Stamenkovic I.

PLoS One. 2011;6(8):e23592. doi: 10.1371/journal.pone.0023592. Epub 2011 Aug 10.

15.

MicroRNA-20b promotes cell proliferation via targeting of TGF-β receptor II and upregulates MYC expression in Ewing's sarcoma cells.

Kawano M, Tanaka K, Itonaga I, Iwasaki T, Tsumura H.

Int J Oncol. 2017 Dec;51(6):1842-1850. doi: 10.3892/ijo.2017.4155. Epub 2017 Oct 12.

PMID:
29039480
16.

Let-7a functions as a tumor suppressor in Ewing's sarcoma cell lines partly by targeting cyclin-dependent kinase 6.

Zhang Z, Huang L, Yu Z, Chen X, Yang D, Zhan P, Dai M, Huang S, Han Z, Cao K.

DNA Cell Biol. 2014 Mar;33(3):136-47. doi: 10.1089/dna.2013.2179. Epub 2014 Jan 2.

17.

MicroRNA expression during osteogenic differentiation of human multipotent mesenchymal stromal cells from bone marrow.

Gao J, Yang T, Han J, Yan K, Qiu X, Zhou Y, Fan Q, Ma B.

J Cell Biochem. 2011 Jul;112(7):1844-56. doi: 10.1002/jcb.23106.

PMID:
21416501
18.

[DNA microarrays-based microRNA expression profiles derived from formalin-fixed paraffin-embedded tissue blocks of squammous cell carcinoma of larynx].

Li L, Zhang ZM, Liu Y, Wei MH, Xue LY, Zou SM, Di XB, Han NJ, Zhang KT, Xu ZG, Gao YN.

Zhonghua Bing Li Xue Za Zhi. 2010 Jun;39(6):391-5. Chinese.

PMID:
21055156
19.

Embryonic stem cell microRNAs: defining factors in induced pluripotent (iPS) and cancer (CSC) stem cells?

Gunaratne PH.

Curr Stem Cell Res Ther. 2009 Sep;4(3):168-77. Review.

PMID:
19492978
20.

Identification of differentially expressed microRNAs by microarray: a possible role for microRNAs gene in medulloblastomas.

Liu W, Gong YH, Chao TF, Peng XZ, Yuan JG, Ma ZY, Jia G, Zhao JZ.

Chin Med J (Engl). 2009 Oct 20;122(20):2405-11.

PMID:
20079150

Supplemental Content

Support Center